Next |
home / stock / snpx / snpx message board
Subject | By | Source | When |
---|---|---|---|
I agree in principal but unless NIH funds | runncoach | investorshub | 04/14/2023 6:55:44 PM |
I don't think Bryostatin is done. I | Battle Ready | investorshub | 04/14/2023 4:34:29 PM |
If Bryostatin is done for work and I | runncoach | investorshub | 04/14/2023 4:22:05 PM |
I had only kept 1000 shares of Petros, | Battle Ready | investorshub | 04/14/2023 4:19:14 PM |
Anyone that still has shares of petros from | runncoach | investorshub | 04/14/2023 4:10:24 PM |
I didn't listen but not sure how that | runncoach | investorshub | 04/14/2023 4:08:27 PM |
On the brief recently concluded call that we | Battle Ready | investorshub | 04/14/2023 3:13:11 PM |
Yeah sure they have. Faked out everyone including | runncoach | investorshub | 04/13/2023 9:53:39 PM |
Insiders have always known this was a FAIL!!!!! | XenaLives | investorshub | 04/13/2023 9:44:06 PM |
Sorry. No I meant 1.25 isn't the real | runncoach | investorshub | 04/11/2023 5:46:17 PM |
Are you saying that you interpret the filing | Battle Ready | investorshub | 04/11/2023 4:53:36 PM |
I think the price will be a minimum | runncoach | investorshub | 04/11/2023 4:50:28 PM |
Yeah they were able to amend the previous | runncoach | investorshub | 04/11/2023 4:45:45 PM |
Does anyone know the minimum share price for | Battle Ready | investorshub | 04/11/2023 1:53:38 PM |
In fact, more than 50% of all deaths | XenaLives | investorshub | 04/04/2023 1:40:39 AM |
Thanks Doc. | runncoach | investorshub | 04/02/2023 4:59:52 PM |
I don't regularly check for markers of inflammation | Doc328 | investorshub | 04/02/2023 4:47:53 PM |
Doc, I don't if you'll be able to | runncoach | investorshub | 04/02/2023 4:24:51 PM |
I actually posted on the $AVXL page Friday | Doc328 | investorshub | 04/02/2023 2:54:55 PM |
Any thoughts on TLSA/Foralumab? | redspinelpinktopaz | investorshub | 04/02/2023 2:35:29 PM |
News, Short Squeeze, Breakout and More Instantly...
Synaptogenix Inc. Company Name:
SNPX Stock Symbol:
OTCMKTS Market:
Synaptogenix Applauds DEA Proposal to Reclassify Cannabis and Shares Expected Benefits to Cannasoul for Cannabinoid-Based Drug Discovery PR Newswire Proposed Schedule III drug classification expected to de-risk Cannasoul's cannabis research and potential regulatory pathways ...
Synaptogenix Regains Compliance with Nasdaq Minimum Bid Price Requirement for Continued Listing PR Newswire NEW YORK , April 24, 2024 /PRNewswire/ -- Synaptogenix, Inc. (Nasdaq: SNPX) ("Synaptogenix" or the "Company"), an emerging biopharmaceutical company develo...